Percutaneous Coronary Intervention for Coronary Events during Tyrosine Kinase Inhibitor Therapy in Leukemia Patients
International Heart Journal · 30.05.2026 · 67 (3) · 275-279
DOI: 10.1536/ihj.26-033 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Heart Journal, erschienen am 30.05.2026. Verfasst von Asaki Saijo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Toranomon Hospital. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Percutaneous Coronary Intervention, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Toranomon Hospital.
Zitieren
APA
Saijo, A., Yamaguchi, T., Konishi, A., Maze, Y., Komiyama, C., Harima, A., Fujimoto, Y., & Kodama, T. (2026). Percutaneous Coronary Intervention for Coronary Events during Tyrosine Kinase Inhibitor Therapy in Leukemia Patients. International Heart Journal, 67(3), 275-279. https://doi.org/10.1536/ihj.26-033
Vancouver
Saijo A, Yamaguchi T, Konishi A, Maze Y, Komiyama C, Harima A, et al. Percutaneous Coronary Intervention for Coronary Events during Tyrosine Kinase Inhibitor Therapy in Leukemia Patients. International Heart Journal. 2026;67(3):275-279. doi:10.1536/ihj.26-033
BibTeX
@article{Saijo2026,
author = {Saijo, Asaki and Yamaguchi, Tetsuo and Konishi, Akinori and Maze, Yuki and Komiyama, Chinatsu and Harima, Ayako and Fujimoto, Yo and Kodama, Takahide},
title = {Percutaneous Coronary Intervention for Coronary Events during Tyrosine Kinase Inhibitor Therapy in Leukemia Patients},
journal = {International Heart Journal},
year = {2026},
volume = {67},
number = {3},
pages = {275--279},
doi = {10.1536/ihj.26-033}
}
EUVIMED